JAMIE CORDOBA: Open Payments
NPI 1538254040 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,011 in 96 payments from 19 companies in 2025. Trend: 2023 $3,517 · 2024 $4,086 · 2025 $3,011
Food & beverage: $3,011
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $431 |
| Arcutis Biotherapeutics, Inc. | 15 | $426 |
| Incyte Corporation | 15 | $420 |
| ABBVIE INC. | 10 | $384 |
| Regeneron Healthcare Solutions, Inc. | 8 | $273 |
| Galderma Laboratories, L.P. | 8 | $225 |
| E.R. Squibb & Sons, L.L.C. | 2 | $158 |
| LEO Pharma Inc. | 7 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $121 |
| UCB, Inc. | 3 | $107 |
Products named: DUPIXENT, Zoryve, OPZELURA, SKYRIZI, NEMLUVIO, Sotyktu, ILUMYA, ADBRY.
Industry payments across CA — which companies pay providers there.
